Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Peringkat dalam Saham #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Harga Saham
$29.86
Terakhir disinkronkan: 2026-08-19
Kapitalisasi Pasar
$2.48B
Perubahan (1 hari)
4.92%
Perubahan (1 tahun)
502.82%
Negara
TW
Perdagangan Lin BioScience, Inc. (6696)

Kategori

Riwayat pemecahan saham untuk Lin BioScience, Inc. (6696)
Saham Lin BioScience, Inc. (simbol: 6696) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 27, 2026.
Satu lembar saham 6696 yang dibeli sebelum Aug 27, 2026 sekarang setara dengan 0 lembar saham 6696.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH